These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 3326155)

  • 1. [New etiopathogenic and therapeutic findings in bullous skin diseases].
    Rozsívalová V; Jelínková R; Salavec M; Chýlková V
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1986; 29(4-5):497-512. PubMed ID: 3326155
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mechanisms of therapeutic effect of extracorporeal detoxication in autoimmune bullous dermatoses].
    Grando SA; Glukhen'kiĭ BT; Romanenko AB; Chaiun OA; Dolia SV
    Vestn Dermatol Venerol; 1988; (7):6-11. PubMed ID: 3064487
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunological studies of patients with vesicular diseases].
    Seidlová A
    Cesk Stomatol; 1983 Jul; 83(4):245-50. PubMed ID: 6375878
    [No Abstract]   [Full Text] [Related]  

  • 4. [Bullous diseases and their monitoring at the dermatology clinic].
    Rozsívalová V
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1987; 30(5):687-94. PubMed ID: 3333100
    [No Abstract]   [Full Text] [Related]  

  • 5. [Plasma exchange therapy in pemphigus vulgaris and bullous pemphigoid--our clinical experiences and the role of bullous pemphigoid antibody in blister formation].
    Watanabe S
    Nihon Hifuka Gakkai Zasshi; 1983 Aug; 93(9):953-64. PubMed ID: 6363766
    [No Abstract]   [Full Text] [Related]  

  • 6. [Plasmapheresis in the treatment of bullous skin diseases].
    Neumann E; Skalisz H; Bowszyc J
    Przegl Dermatol; 1980; 67(4):487-92. PubMed ID: 7001548
    [No Abstract]   [Full Text] [Related]  

  • 7. Autoimmune bullous dermatoses.
    Cunha PR; Barraviera SR
    An Bras Dermatol; 2009; 84(2):111-24. PubMed ID: 19503978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunopathological aspects of autoimmune bullous dermatoses].
    Grando SA; Glukhen'kiĭ BT; Kutsenko NS; Kostromin AP; Demidov SV
    Vrach Delo; 1987 Sep; (9):94-7. PubMed ID: 3321707
    [No Abstract]   [Full Text] [Related]  

  • 9. Concomitant immunohistochemical characteristics of pemphigoid and dermatitis herpetiformis in a patient with atypical bullous dermatosis.
    de Jong MC; van der Meer JB; de Nijs JA; van der Putte SC
    Acta Derm Venereol; 1983; 63(6):476-82. PubMed ID: 6198835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vesiculobullous skin disease with prominent immunologic feature.
    Millikan LE
    JAMA; 1987 Nov; 258(20):2910-5. PubMed ID: 3312674
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment Update of Autoimmune Blistering Diseases.
    Kridin K; Ahn C; Huang WC; Ansari A; Sami N
    Dermatol Clin; 2019 Apr; 37(2):215-228. PubMed ID: 30850044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of beta 1H globulin in pemphigus, bullous pemphigoid and dermatitis herpetiformis (author's transl)].
    Sugiura M
    Nihon Hifuka Gakkai Zasshi; 1982 May; 92(6):629-34. PubMed ID: 6213797
    [No Abstract]   [Full Text] [Related]  

  • 13. Autoimmune bullous diseases.
    Rye B; Webb JM
    Am Fam Physician; 1997 Jun; 55(8):2709-18. PubMed ID: 9191456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunopathology of pemphigus vulgaris, bullous pemphigoid and related bullous dermatoses.
    Patel HP; Anhalt GJ; Provost TT; Diaz LA
    Clin Immunol Rev; 1983-1984; 2(2):157-86. PubMed ID: 6370527
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunology of bullous diseases-II. Cicatricial pemphigoid. Herpes gestationis and dermatitis herpetiformis].
    Díaz-Pérez JL; Jordón RE
    Med Cutan Ibero Lat Am; 1977; 5(6):403-13. PubMed ID: 368462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bullous pemphigoid and pemphigus vulgaris.
    Patel HP; Anhalt GJ; Diaz LA
    Ann Allergy; 1983 Mar; 50(3):144-50. PubMed ID: 6338766
    [No Abstract]   [Full Text] [Related]  

  • 17. Value of immunofluorescent techniques in studies of bullous disease.
    Maize JC; Provost TT
    Am J Dermatopathol; 1983 Feb; 5(1):67-72. PubMed ID: 6344686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of raised production of eicosanoids during the increase of immunosuppressive activity of the serum after hemosorption].
    Grando SA; Drannik GN
    Biull Eksp Biol Med; 1990 Feb; 109(2):172-4. PubMed ID: 2186817
    [No Abstract]   [Full Text] [Related]  

  • 19. Three blistering diseases. Why proper management is critical.
    Wooldridge WE
    Postgrad Med; 1990 Sep; 88(3):103-4, 106. PubMed ID: 2204894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vesiculobullous skin diseases with prominent immunologic feature.
    Zweiman B; Millikan LE
    JAMA; 1982 Nov; 248(20):2623-6. PubMed ID: 6754973
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.